Vaccinomics to Design a Multiepitope Vaccine against Legionella pneumophila

Figure 3

(a–c) Vaccine construct sequence along with predicted structure and structure evaluation analysis: (a) depicts the sequence of the vaccine after addition of different linkers and an adjuvant; (b) is the predicted structure of the vaccine using I-TASSER server; (c) describes the conformational analysis of the structure, and the red zones in that plot indicated the favored regions and the number of residues in it.

(a)

(b)

(c)